Monetary Woes, Healthcare Blues: The Consequences of Inflation & its Effect on the Cost of Critical Medicines
Summary
The report details how inflation has dramatically increased the prices of critical medications in Nigeria, such as insulin and blood pressure drugs, leading to patient rationing and worsened health outcomes. It highlights a systemic lack of drug price control mechanisms in Nigeria and calls for government intervention through subsidies and price controls to prevent increased mortality and healthcare costs.
Key insights
- Nigeria currently lacks a fixed mechanism for the reimbursement or control of drug prices, which the report identifies as a sign of weak economic policies regarding essential commodities.
- A survey of essential medications between 2023 and 2024 showed dramatic price increases: Amlodipine (for high blood pressure) rose from N1,500 to N3,000 per pack, and Paracetamol increased from N200 to N500 per pack.
- The cost of Lidocaine, an anaesthetic used in surgeries, more than doubled from N2,000 to N4,500, leading hospitals to raise surgical fees and causing some essential procedures to be delayed or abandoned.
- Insulin prices in Nigeria have surged by 100% to N12,000, forcing some diabetic patients to ration or skip doses, which increases the risk of organ failure, ketoacidosis, and death.
- The inability to afford medications creates a cycle of escalating costs, as untreated chronic conditions lead to more frequent emergency room visits and hospitalisations.
- Inflation-driven medication costs disproportionately affect low-income families and the elderly on fixed incomes, often forcing trade-offs between healthcare and basic needs like food and housing, or leading patients to halve their dosages.
Cite the original document
- APA
- Okeowo, G., Iseniyi, O., Okorie, P. C., Okoloeze, E., Kwaga, V., & Usen, I. (2024). Monetary Woes, Healthcare Blues: The Consequences of Inflation & its Effect on the Cost of Critical Medicines. BudgIT. https://budgit.org/wp-content/uploads/2025/04/Monetary-Woes-Healthcare-Blues-2.pdf
- Chicago
- Okeowo, Gabriel, Oluwatosin Iseniyi, Precious Chima Okorie, Esther Okoloeze, Vahyala Kwaga, and Iniobong Usen. Monetary Woes, Healthcare Blues: The Consequences of Inflation & its Effect on the Cost of Critical Medicines. BudgIT, 2024. https://budgit.org/wp-content/uploads/2025/04/Monetary-Woes-Healthcare-Blues-2.pdf.
- Wikipedia
- {{cite report |last1=Okeowo |first1=Gabriel |last2=Iseniyi |first2=Oluwatosin |last3=Okorie |first3=Precious Chima |last4=Okoloeze |first4=Esther |last5=Kwaga |first5=Vahyala |last6=Usen |first6=Iniobong |title=Monetary Woes, Healthcare Blues: The Consequences of Inflation & its Effect on the Cost of Critical Medicines |publisher=BudgIT |date=2024 |url=https://budgit.org/wp-content/uploads/2025/04/Monetary-Woes-Healthcare-Blues-2.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document budgit-000175)}}
- BibTeX
- @techreport{okeowo2024monetary, author = {Okeowo, Gabriel and Iseniyi, Oluwatosin and Okorie, Precious Chima and Okoloeze, Esther and Kwaga, Vahyala and Usen, Iniobong}, title = {{Monetary Woes, Healthcare Blues: The Consequences of Inflation \& its Effect on the Cost of Critical Medicines}}, institution = {BudgIT}, year = {2024}, url = {https://budgit.org/wp-content/uploads/2025/04/Monetary-Woes-Healthcare-Blues-2.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document budgit-000175} }
Full text
Collected · Record updated